The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Spevigo (spesolimab)
Australian Public Assessment Report
Device/Product Name
Spevigo
Active ingredients
Spesolimab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-01272-1-1
Submission Type
New biological entity
Decision
Approved